Lineage Cell Therapeutics (LCTX)'s 30-day implied volatility (IV30) was 50.9% at the close on November 3, 2026, down from 66.7% the day before, against a 52-week range of 43.8% to 116.9%. Its 20-day historical volatility was 61.4%.
Data as of November 3, 2026.